2m 2m 2m 2m 2m 2m 2m
Q32 BIO (QTTB)
NASDAQ
$8.83+$0.16 (+1.80%)
Price as of Oct 22, 2026 7:50 PM EDT- $258.1MMarket Cap
- 227.17%1-Year Change
- BiotechnologyIndustry
Q32 BIO (QTTB)
$8.83+$0.16 (+1.80%)
QTTB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.67 | ||
Change | +$0.05 (+0.58%) | ||
Open | $8.62 | ||
High | $8.81 | ||
Low | $8.55 | ||
Previous Close | $8.62 | ||
Volume | 322,325 | ||
30-Day Average Volume | 1,064,275 | ||
1-Week Change | 8.24% | ||
1-Month Change | -17.19% | ||
1-Year Change | 227.17% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 29.8M | ||
Total Assets | $115.9M | ||
Market Cap | $258.1M | ||
Enterprise Value | $151.8M | ||
Period: QTR TTM FY | |||
Revenue | -$246,000.00 | ||
Net Income | -$8.9M | ||
Free Cash Flow | -$3.1M | ||
EBIT | -$8.7M | ||
EBITDA | -$8.7M | ||
Net Working Capital | $104.2M | ||
EPS | -$0.44 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | -617 | ||
P/B | 2 | ||
P/E | -20 | ||
PEG | -1 | ||
Price/Free Cash Flow | -84 | ||
Price/Operating Cash Flow | -84 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue